Characteristics and Clinical Status
In modern medical practice, Praziquantel (Praziquantelum) rightfully holds the status of drug of choice (the gold standard) for pharmacotherapy of corresponding parasitic infestations. Clinicians favor it due to its proven efficacy and high clinical significance in combating severe, life-threatening conditions.
Spectrum of Pharmacological Action
The pharmacological activity of the drug extends to key groups of flatworms:
- Cestodes: Active against adult tapeworm forms.
- Trematodes: Effectively eradicates flatworms and flukes.
The drug is of particular clinical importance for the treatment of schistosomiasis, a widespread infection characterized by extremely high morbidity and severe mortality rates worldwide.
Mechanism of Action on Helminths
Although the exact mechanism of the drug has not yet been fully elucidated by researchers, the leading scientific hypothesis explains its effects as follows:
- The active substance sharply increases the permeability of the parasite's cell membranes to calcium ions ($Ca^{2+}$).
- The influx of calcium ions into the cells causes sustained, continuous contraction of the helminth's musculature.
- The end result is spastic paralysis of the worm, leading to its death and elimination from the host's body.
Safety Profile and Adverse Reactions
Like any active pharmacological agent, Praziquantel has a specific spectrum of side effects that clinicians must consider:
- Dyspeptic disorders: Patients frequently report nausea and mild abdominal discomfort.
- Neurological symptoms: Headache is the most commonly reported neurological side effect.